Summary: H.R.5145 — 114th Congress (2015-2016)All Information (Except Text)

There is one summary for H.R.5145. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (04/29/2016)

This bill amends title XIX (Medicaid) of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the requirement that manufacturers of single-source or innovator drugs pay additional rebates to state Medicaid programs.

Under current law, the Centers for Medicare & Medicaid Services (CMS) must use predictive modeling and other analytic technologies to identify improper Medicaid claims. The bill prohibits a state agency from using or disclosing such technologies except for purposes of administering a state Medicaid program or Children's Health Insurance Program (CHIP). A state agency shall have in effect adequate data security and control policies to ensure that access to such information is restricted to authorized persons for authorized uses.

The bill places $5 million in the Medicaid Improvement Fund to be available beginning in FY2021.